Ina Giele

Ina Giele is a researcher affiliated with the Department of Clinical Genetics at Erasmus MC. Her work focuses on cancer genetics, hereditary cancer syndromes, and genetic epidemiology. She collaborates internationally on studies investigating CHEK2, BRCA2, and PALB2 gene variants' roles in cancer risk. Key projects include nationwide cohort studies on hereditary breast and ovarian cancer, and analyses of germline variants in breast cancer survival. Her research spans genetic counseling, mismatch repair deficiencies, and exome sequencing applications.

• Primary affiliation: Erasmus MC, Department of Clinical Genetics
• Research collaborations with institutions in Europe and globally

Research interests emphasize translational genetics, particularly in identifying genetic markers for cancer predisposition and improving clinical risk assessment. Recent studies address multisite cancer risks in CHEK2 mutation carriers and the impact of germline variants on contralateral breast cancer outcomes.